Continuing Research and Development Activities
First written in FY2017-Q1. 24 of 29 entries say "Restated". Latest entry: FY2026-H1.
- FY2026-H1RestatedAnnual report
「R&D expenditure by the Group as a whole during the interim consolidated fiscal period was ¥632 million. There was no material change in the status of the Group's R&D activities during the period.」
The Company continued its R&D activities and disclosed interim R&D expenditure of ¥632 million. It stated that there had been no material change in the status of its R&D activities. - FY2025AdvancedAnnual report
「Total R&D expenditure for the consolidated fiscal year was ¥1.052 billion, almost all of which related to the Company's own products business. An overview of R&D activities by field is provided below.」
R&D expenditure increased from ¥1.028 billion in the previous fiscal year to ¥1.052 billion, and the Company developed products including ASTM-compliant coated copper pipe, Eco Void Sleeve, EV Outlet Pole and automotive warning lights. - FY2025-H1RestatedAnnual report
「R&D expenditure by the Group as a whole during the interim consolidated fiscal period was ¥548 million. There was no material change in the status of the Group's R&D activities during the period.」
The Company disclosed interim R&D expenditure of ¥548 million and stated that there had been no material change in the status of its R&D activities. - FY2024AdvancedAnnual report
「The Company developed Anthracite, a color for its Slim Duct SD air-conditioning pipe cover for overseas markets, enabling installations that blend with the dark-colored exterior walls traditionally used for homes in Europe and elsewhere.」
The Company recorded full-year R&D expenditure of ¥1.028 billion and developed new products in the air-conditioning, plumbing and equipment materials, housing-related and indicator-light fields. - FY2024-Q3RestatedAnnual report
「R&D expenditure by the Group as a whole during the third quarter of the current cumulative consolidated fiscal period was ¥769 million. There was no material change in the status of the Group's R&D activities during the period.」
The Company continued its R&D activities and disclosed cumulative third-quarter R&D expenditure of ¥769 million. It stated that there had been no material change in the status of its R&D activities. - FY2024-Q2RestatedAnnual report
「R&D expenditure by the Group as a whole during the second quarter of the current cumulative consolidated fiscal period was ¥497 million. There was no material change in the status of the Group's R&D activities during the period.」
The Company continued its R&D activities and disclosed cumulative second-quarter R&D expenditure of ¥497 million. It stated that there had been no material change in the status of its R&D activities. - FY2024-Q1RestatedAnnual report
「R&D expenditure by the Group as a whole during the first quarter of the current cumulative consolidated fiscal period was ¥187 million. There was no material change in the status of the Group's R&D activities during the period.」
The Company continued its R&D activities and disclosed cumulative first-quarter expenditure of ¥187 million. It stated that there had been no material change in the status of its R&D activities. - FY2023-Q3RestatedAnnual report
「R&D expenditure by the Group as a whole during the third quarter of the current cumulative consolidated fiscal period was ¥614 million. There was no material change in the status of the Group's R&D activities during the period.」
The Company continued its R&D activities and disclosed cumulative third-quarter expenditure of ¥614 million. - FY2023-Q2RestatedAnnual report
「R&D expenditure by the Group as a whole during the second quarter of the current cumulative consolidated fiscal period was ¥373 million. There was no material change in the status of the Group's R&D activities during the period.」
The Company continued its R&D activities and disclosed cumulative second-quarter R&D expenditure of ¥373 million. - FY2022AdvancedAnnual report
「The Group has identified the development and expansion of its own products as a core pillar of its medium- to long-term management strategy. It is placing particular emphasis on developing new products through the development divisions of the Company and its affiliated companies, while working to expand product variations, improve the functions and quality of existing products, and improve products and manufacturing processes to reduce costs. Total R&D expenditure for the consolidated fiscal year was ¥913 million, almost all of which related to the Company's own products business.」
The Company recorded R&D expenditure of ¥913 million and developed new and improved products including the stainless-steel version of Slim Duct RD, the free corner for Reform Duct JD, Fire-resistant Tape IRTZ and the NHV series. - FY2022-Q3RestatedAnnual report
「R&D expenditure by the Group as a whole during the third quarter of the current cumulative consolidated fiscal period was ¥684 million.」
The Company continued its R&D activities and disclosed cumulative third-quarter R&D expenditure of ¥684 million. It also stated that there had been no material change in the status of its R&D activities. - FY2022-Q1RestatedAnnual report
「R&D expenditure by the Group as a whole during the first quarter of the current cumulative consolidated fiscal period was ¥224 million.」
The Company continued its R&D activities and disclosed cumulative first-quarter R&D expenditure of ¥224 million. It stated that there had been no material change in the status of its R&D activities. - FY2021AdvancedAnnual report
「The Group has identified the development and expansion of its own products as a core pillar of its medium- to long-term management strategy. It is placing particular emphasis on developing new products through the development divisions of the Company and its affiliated companies, while working to expand product variations, improve the functions and quality of existing products, and improve products and manufacturing processes to reduce costs. Total R&D expenditure for the consolidated fiscal year was ¥965 million, almost all of which related to the Company's own products business.」
The Company continued to position R&D as a core element of its own products business and disclosed R&D expenditure of ¥965 million, along with the development of new products including Chamber Box, Fire-resistant Neo Sleeve, Network Monitoring Indicator and Auxiliary Warning Light. - FY2021-Q3RestatedAnnual report
「R&D expenditure by the Group as a whole during the third quarter of the current cumulative consolidated fiscal period was ¥716 million.」
The Company continued its R&D activities and disclosed cumulative third-quarter R&D expenditure of ¥716 million. It also stated that there had been no material change in the status of its R&D activities. - FY2021-Q2RestatedAnnual report
「R&D expenditure by the Group as a whole during the second quarter of the current cumulative consolidated fiscal period was ¥475 million.」
The Company continued its R&D activities and disclosed cumulative second-quarter R&D expenditure of ¥475 million. It stated that there had been no material change in the status of its R&D activities. - FY2021-Q1RestatedAnnual report
「R&D expenditure by the Group as a whole during the first quarter of the current cumulative consolidated fiscal period was ¥207 million.」
The Company continued its R&D activities and disclosed cumulative first-quarter R&D expenditure of ¥207 million. It also stated that there had been no material change in the status of its R&D activities. - FY2020-Q3RestatedAnnual report
「R&D expenditure by the Group as a whole during the third quarter of the current cumulative consolidated fiscal period was ¥678 million.」
The Company continued its R&D activities and disclosed cumulative R&D expenditure of ¥678 million through the third quarter. It also stated that there had been no material change in the status of its R&D activities. - FY2020-Q2RestatedAnnual report
「R&D expenditure by the Group as a whole during the second quarter of the current cumulative consolidated fiscal period was ¥443 million.」
The Company continued its R&D activities and disclosed cumulative R&D expenditure of ¥443 million through the second quarter. It also stated that there had been no material change in the status of its R&D activities. - FY2020-Q1RestatedAnnual report
「R&D expenditure by the Group as a whole during the first quarter of the current cumulative consolidated fiscal period was ¥198 million.」
The Company continued its R&D activities and disclosed cumulative R&D expenditure through the first quarter. It also stated that there had been no material change in the status of its R&D activities. - FY2019RestatedAnnual report
「Total R&D expenditure for the consolidated fiscal year was ¥908 million, almost all of which related to the Company's own products business.」
The Company continued its R&D activities and disclosed full-year R&D expenditure of ¥908 million. - FY2019-Q3RestatedAnnual report
「R&D expenditure by the Group as a whole during the third quarter of the current cumulative consolidated fiscal period was ¥660 million.」
The Company continued its R&D activities and disclosed cumulative R&D expenditure through the third quarter. It also stated that there had been no material change in the status of its R&D activities. - FY2019-Q2RestatedAnnual report
「R&D expenditure by the Group as a whole during the second quarter of the current cumulative consolidated fiscal period was ¥422 million.」
The Company continued its R&D activities and disclosed cumulative R&D expenditure through the second quarter. It also stated that there had been no material change in the status of its R&D activities. - FY2019-Q1RestatedAnnual report
「R&D expenditure by the Group as a whole during the first quarter of the current cumulative consolidated fiscal period was ¥204 million.」
The Company continued its R&D activities and disclosed cumulative R&D expenditure through the first quarter. It also stated that there had been no material change in the status of its R&D activities. - FY2018-Q3RestatedAnnual report
「R&D expenditure by the Group as a whole during the third quarter of the current cumulative consolidated fiscal period was ¥691 million.」
The Company continued its R&D activities and disclosed cumulative R&D expenditure through the third quarter. - FY2018-Q2RestatedAnnual report
「R&D expenditure by the Group as a whole during the second quarter of the current cumulative consolidated fiscal period was ¥459 million.」
The Company continued its R&D activities and disclosed cumulative R&D expenditure through the second quarter. - FY2018-Q1RestatedAnnual report
「R&D expenditure by the Group as a whole during the first quarter of the current cumulative consolidated fiscal period was ¥227 million.」
The Company continued its R&D activities and disclosed cumulative R&D expenditure through the first quarter. - FY2017-Q3RestatedAnnual report
「R&D expenditure by the Group as a whole during the third quarter of the current cumulative consolidated fiscal period was ¥642 million.」
The Company continued its R&D activities and disclosed cumulative R&D expenditure through the third quarter. - FY2017-Q2RestatedAnnual report
「R&D expenditure by the Group as a whole during the second quarter of the current cumulative consolidated fiscal period was ¥420 million.」
The Company continued its R&D activities and disclosed cumulative R&D expenditure through the second quarter. - FY2017-Q1First statedAnnual report
「R&D expenditure by the Group as a whole during the first quarter of the current cumulative consolidated fiscal period was ¥189 million.」
The Company recorded R&D expenditure of ¥189 million for the quarter.